V65I (p.Val65Ile) variant of ACVR1 (Activin receptor type-1)

V65I (p.Val65Ile) in ACVR1 (Activin receptor type-1) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as benign in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.41 / 1. The record also includes population frequency data and structural context.

V65I (p.Val65Ile) variant details